Views & Analysis Growing up different and not knowing why: My experience of r... Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone.
Views & Analysis Cytisinicline - the solution to stop smoking? Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance.
Views & Analysis The power of communication: engaging diverse groups in healt... Humans are diverse and communications to engage us need to be inclusive.
Patients The hidden danger of isolated congenital asplenia TEAM 4 Travis is an advocacy group with one objective – to ensure it doesn’t take an autopsy to diagnose isolated congenital asplenia.
Patients Patient involvement in trial design: looking to the future COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement.
Views & Analysis How accidental advocacy is amplifying the GM1 voice Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.